Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Large, simple vaccine safety trials needed for conclusive adverse event data -- FDA's Ellenberg.

Executive Summary

LARGE, SIMPLE VACCINE SAFETY TRIALS COULD ILLUMINATE WHETHER ADVERSE EVENTS are coincidental and not vaccine-induced, CBER Division of Biostatistics and Epidemiology Director Susan Ellenberg, PhD, told an Oct. 24 Drug Information Association meeting in Bethesda, Md. "This is my own proposal," Ellenberg emphasized. "It is not anything that FDA is about to go out and require you to do. But I think it is a useful thing to think about."
UsernamePublicRestriction

Register

PS029084

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel